click below
click below
Normal Size Small Size show me how
onc exam 1 targets
| DRUG(S) | TARGET(S) |
|---|---|
| gefitinib osimertinib cetuximab panitumumab | EGFR |
| lapatinib | EGFR and HER2 |
| afatinib | EGFR, HER2, and HER4 |
| tucatinib trastuzumab pertuzumab | HER2 |
| crizotinib alectinib brigatinib ensartinib lorlatinib | ALK, ROS1 |
| midostaurin quizartinib | FLT3 |
| entrectinib larotrectinib repotrectinib | TRK, ROS1 |
| pralsetinib selpercatinib | RET |
| amivantamab capmatinib tepotinib | MET |
| acalabrutinib zanubrutinib | BTK |
| asciminib bosutinib dasatinib imatinib nilotinib ponatinib | BCR-ABL |
| dabrafennib encorafenib | B-RAF |
| trametinib binimetinib | MEK, BRAF |
| abemaciclib palbociclib ribociclib | CDK |
| bevacizumab | VEGF-A |
| atezolizumab burvalumab | PD-L1 |
| cemipilimab nivolumab pembrilizumab | PD-1 |
| blinatumomab | CD19/3 |
| rituximab obinutuzumab | CD20 |
| venetoclax | BCL2 |
| thalidome lenalidomide | bFGF |
| Asparagine |